58061-99-7

Upstream product

• 4707-47-5 2,4-dihydroxy-3,6-dimethyl-benzoic acid methyl ester 
• 77-78-1 dimethyl sulfate 
• 56410-34-5 2,4-O-dimethyl-β-orcinolcarboxylic acid 
• 4707-46-4 2,4-dihydroxy-3,6-dimethylbenzoic acid 
• 74-88-4 methyl iodide 
• 38629-37-7 ethyl 2-hydroxy-3-formyl-4-methoxy-6-methylbenzoate 
• 38629-38-8 ethyl 2,4-dimethoxy-3,6-dimethylbenzoate 
• 56410-33-4 ethyl 2-hydroxy-4-methoxy-3,6-dimethylbenzoate 
• 6110-36-7 ethyl everninate 

Downstream Products

• 38629-46-8 methyl 5-bromo-2,4-dimethoxy-3,6-dimethylbenzoate 
• 254756-73-5 3,6-dimethyl-5-methoxy-2-(hydroxymethyl)anisol 
• 874771-62-7 6-[2-(2,3-dimethoxy-phenyl)-ethyl]-2,4-dimethoxy-3-methyl-benzoic acid methyl ester 
• 33561-98-7 3,5-dimethoxy-4-methyl-phthalic acid 
• 34883-15-3 4-methoxy-3,6-dimethyl-2-hydroxybenzaldehyde 
• 38629-39-9 2,4-Dimethoxy-3,6-dimethylbenzaldehyde 
• 38629-49-1 5-Jod-2,4-dimethoxy-3,6-dimethylbenzoat 
• 101908-84-3 formyl-3-dimethoxy-4,6-dimethyl-2,5-benzoate de methyle 

Relevant academic research and scientific papers

Isolation, Chemical Modification, and Anticancer Activity of Major Metabolites of the Lichen Parmotrema mesotropum

Extensive chromatographic purification of the chloroform–methanol (1:1) extract of the lichen Parmotrema mesotropum led to the isolation of methyl hematommate (1), methyl-2,4-dihydroxy-3,6-dimethylbenzoate (2), orcinol (3), and atranorin (4). The two majo

A direct and mild formylation method for substituted benzenes utilizing dichloromethyl methyl ether-silver trifluoromethanesulfonate

A silver trifluoromethanesulfonate (AgOTf)-promoted direct and mild formylation of benzenes has been developed. The reaction utilizing dichloromethyl methyl ether (Cl2CHOMe) and AgOTf powerfully formylated various substituted benzenes under temperature conditions as low as -78 C without losing the protecting groups on the phenolic hydroxyl group.

Total synthesis of racemosol and de-O-methylracemosol, potent cyclooxygenase (COX) inhibitors and antimalarial agents

The total synthesis of antimalarial and cyclooxygenase inhibitors, racemosol and de-O-methylracemosol, is described. The key steps involved the lateral lithiation reaction of ortho-methyl tolulate and the pyran formation via a tandem demethylation-cycliza